Aim for remission or "personal best" using combination DMARD therapy with methotrexate and hydroxychloroquine

Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S95-101.

Abstract

Combination disease-modifying antirheumatic drug therapy with methotrexate and hydroxychloroquine has changed the course of rheumatoid arthritis. Better management requires "front of the line" care, effective drug combinations, and a goal of "Personal Best." The Pincus phenomenon--the discrepancy between subjective satisfaction and objective progression--may be minimized in clinical practice by questionnaires and Snapshot.

Publication types

  • Review

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Drug Therapy, Combination
  • Humans
  • Hydroxychloroquine / therapeutic use*
  • Methotrexate / therapeutic use*
  • Surveys and Questionnaires
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine
  • Methotrexate